MCID: LPC002
MIFTS: 40

Lip Cancer

Categories: Cancer diseases, Gastrointestinal diseases, Oral diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Lip Cancer

MalaCards integrated aliases for Lip Cancer:

Name: Lip Cancer 11 14 16 33
Malignant Neoplasm of Oral Aspect of Lip, Not Specified Whether Upper or Lower 11 33
Malignant Neoplasm of Lip 11 31
Malignant Tumour of Lip 11 33
Lip Neoplasms 43 71
Malignant Neoplasm of Buccal Aspect of Lip, Not Specified Whether Upper or Lower 33
Malignant Neoplasm of Frenulum of Lip, Not Specified Whether Upper or Lower 33
Malignant Neoplasm of Mucosa of Lip, Not Specified Whether Upper or Lower 33
Malignant Neoplasm of External Lip, Not Specified As Upper or Lower 11
Primary Malignant Neoplasm of Vermilion Border of Upper Lip 33
Primary Malignant Neoplasm of Vermilion Border of Lower Lip 33
Primary Malignant Neoplasm of Vermilion Border of Lip 33
Malignant Neoplasm of Vermilion Border of Upper Lip 33
Malignant Neoplasm of Vermilion Border of Lower Lip 33
Malignant Neoplasm of Lipstick Area of Upper Lip 33
Malignant Neoplasm of Lipstick Area of Lower Lip 33
Malignant Neoplasm of Buccal Aspect of Upper Lip 33
Malignant Neoplasm of Buccal Aspect of Lower Lip 33
Primary Malignant Neoplasm of Commissure of Lip 33
Malignant Neoplasm of Labial Commissure of Lip 11
Malignant Neoplasm of Lower Lip, Buccal Aspect 11
Malignant Neoplasm of Oral Aspect of Upper Lip 33
Malignant Neoplasm of Oral Aspect of Lower Lip 33
Malignant Neoplasm of Lower Lip, Inner Aspect 11
Malignant Neoplasm of Vermilion Border of Lip 11
Malignant Neoplasm of Lower Lip, Oral Aspect 11
Malignant Neoplasm of Lip, Vermilion Border 11
Malignant Neoplasm of Frenulum of Upper Lip 33
Malignant Neoplasm of Frenulum of Lower Lip 33
Malignant Neoplasm of Vermilion Border Nos 33
Malignant Neoplasm of Mucosa of Upper Lip 33
Malignant Neoplasm of Mucosa of Lower Lip 33
Malignant Neoplasm of Other Sites of Lip 11
Malignant Neoplasm of Commissure of Lip 11
Malignant Neoplasm of Lip, Inner Aspect 11
Malignant Neoplasm of Lower Lip, Mucosa 11
Malignant Tumor of Lower Labial Mucosa 11
Malignant Neoplasm of Lip, Unspecified 33
Malignant Tumour of Labial Commissure 11
Malignant Tumor of Commissure of Lip 11
Malignant Neoplasm of Lip, External 11
Malignant Neoplasm of Upper Lip Nos 33
Malignant Neoplasm of Lower Lip Nos 33
Primary Malignant Neoplasm of Lip 33
Malignant Tumor of Labial Mucosa 11
Malignant Tumor of the Lip 11
Malignant Tumor of Lip 11
Upper Lip Cancer 33
Lower Lip Cancer 33
Cancer of Lip 71

Classifications:



External Ids:

Disease Ontology 11 DOID:8564
ICD9CM 34 140 140.6 140.8
MeSH 43 D008048
NCIt 49 C7485
UMLS 71 C0023761 C0153340 C0153346 more

Summaries for Lip Cancer

MalaCards based summary: Lip Cancer, also known as malignant neoplasm of oral aspect of lip, not specified whether upper or lower, is related to lip and oral cavity cancer and squamous cell carcinoma, head and neck. An important gene associated with Lip Cancer is MIR345 (MicroRNA 345), and among its related pathways/superpathways are Oncogene Induced Senescence and let-7 inhibition of ES cell reprogramming. The drugs Erlotinib and Durvalumab have been mentioned in the context of this disorder. Affiliated tissues include lymph node, endothelial and lung.

Related Diseases for Lip Cancer

Diseases in the Lip Cancer family:

Lip Carcinoma in Situ

Diseases related to Lip Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 117)
# Related Disease Score Top Affiliating Genes
1 lip and oral cavity cancer 31.6 TP53 MIR345 CDKN2A
2 squamous cell carcinoma, head and neck 30.0 TP53 MIRLET7E MIR205 CDKN2A
3 head and neck cancer 29.8 TP53 MIR512-1 MIR205 CDKN2A
4 squamous cell carcinoma 29.0 TP53 PDPN MIR205 CDKN2A
5 lower lip cancer 11.3
6 upper lip cancer 11.2
7 skin carcinoma 10.3
8 actinic cheilitis 10.3
9 cheilitis 10.3
10 basal cell carcinoma 10.2
11 b-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) 10.2 TP53 CDKN2A
12 endometrial squamous cell carcinoma 10.2 TP53 CDKN2A
13 esophagus verrucous carcinoma 10.2 TP53 CDKN2A
14 bizarre leiomyoma 10.2 TP53 CDKN2A
15 squamous cell papilloma 10.2 TP53 CDKN2A
16 larynx squamous papilloma 10.2 TP53 CDKN2A
17 suppressor of tumorigenicity 3 10.2 TP53 CDKN2A
18 conjunctival squamous cell carcinoma 10.2 TP53 CDKN2A
19 bladder clear cell adenocarcinoma 10.2 TP53 CDKN2A
20 atypical neurofibroma 10.2 TP53 CDKN2A
21 male urethral cancer 10.2 TP53 CDKN2A
22 chronic cervicitis 10.2 TP53 CDKN2A
23 lymphoepithelioma-like carcinoma 10.2 TP53 CDKN2A
24 basaloid squamous cell carcinoma 10.2 TP53 CDKN2A
25 anal squamous cell carcinoma 10.2 TP53 CDKN2A
26 keratinizing squamous cell carcinoma 10.2 TP53 CDKN2A
27 paranasal sinus cancer 10.2 TP53 CDKN2A
28 idh-wildtype glioblastoma 10.2 TP53 CDKN2A
29 bone squamous cell carcinoma 10.2 TP53 CDKN2A
30 adult malignant schwannoma 10.2 TP53 CDKN2A
31 vaginal cancer 10.2 TP53 CDKN2A
32 pleomorphic xanthoastrocytoma 10.1 TP53 CDKN2A
33 malignant spindle cell melanoma 10.1 TP53 CDKN2A
34 borst-jadassohn intraepidermal carcinoma 10.1 TP53 CDKN2A
35 basal cell carcinoma 1 10.1
36 mixed glioma 10.1 TP53 CDKN2A
37 phimosis 10.1 TP53 CDKN2A
38 uterus carcinoma in situ 10.1 TP53 CDKN2A
39 barrett's adenocarcinoma 10.1 TP53 CDKN2A
40 conjunctival cancer 10.1 TP53 CDKN2A
41 neurofibrosarcoma 10.1 TP53 CDKN2A
42 acanthoma 10.1 TP53 CDKN2A
43 nodular malignant melanoma 10.1 TP53 CDKN2A
44 cervix uteri carcinoma in situ 10.1 TP53 CDKN2A
45 vulva squamous cell carcinoma 10.1 TP53 CDKN2A
46 vulvar disease 10.1 TP53 CDKN2A
47 peritoneum cancer 10.1 TP53 CDKN2A
48 esophagus adenocarcinoma 10.1 TP53 MIR345 CDKN2A
49 plexiform neurofibroma 10.1 TP53 CDKN2A
50 anus cancer 10.1 TP53 CDKN2A

Graphical network of the top 20 diseases related to Lip Cancer:



Diseases related to Lip Cancer

Symptoms & Phenotypes for Lip Cancer

Drugs & Therapeutics for Lip Cancer

Drugs for Lip Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 54)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Erlotinib Approved, Investigational Phase 3 183319-69-9, 183321-74-6 176870
2
Durvalumab Approved, Investigational Phase 2, Phase 3 1428935-60-7
3
Cetuximab Approved Phase 2, Phase 3 205923-56-4
4 Immunoglobulins Phase 2, Phase 3
5 Antibodies Phase 2, Phase 3
6 Antineoplastic Agents, Immunological Phase 2, Phase 3
7 Immunoglobulins, Intravenous Phase 2, Phase 3
8 Immunoglobulin G Phase 2, Phase 3
9 Antibodies, Monoclonal Phase 2, Phase 3
10
Aminolevulinic acid Approved Phase 1, Phase 2 106-60-5 137
11 Orange Approved Phase 1, Phase 2
12
Nivolumab Approved Phase 2 946414-94-4
13
Cemiplimab Approved, Investigational Phase 2 1801342-60-8
14
Carboplatin Approved Phase 2 41575-94-4 10339178 38904
15
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
16 Photosensitizing Agents Phase 1, Phase 2
17 Dermatologic Agents Phase 1, Phase 2
18 Immune Checkpoint Inhibitors Phase 2
19 Mitogens Phase 1, Phase 2
20 Albumin-Bound Paclitaxel Phase 2
21 Antimitotic Agents Phase 2
22 Tubulin Modulators Phase 2
23 Anti-Infective Agents Phase 2
24 Anti-Bacterial Agents Phase 2
25 Antidotes Phase 2
26
Sodium thiosulfate Phase 2
27 Antitubercular Agents Phase 2
28 Antioxidants Phase 2
29 Protective Agents Phase 2
30 Chelating Agents Phase 2
31
Gemcitabine Approved Phase 1 95058-81-4, 122111-03-9 60750
32
Pembrolizumab Approved Phase 1 1374853-91-4 254741536
33
Doxycycline Approved, Investigational, Vet_approved Phase 1 564-25-0 54671203
34
Cisplatin Approved Phase 1 15663-27-1 2767 5702198 441203
35
Nedisertib Investigational Phase 1 1637542-33-6 86292849
36 Antiviral Agents Phase 1
37 Pharmaceutical Solutions Phase 1
38 Antiprotozoal Agents Phase 1
39 Antiparasitic Agents Phase 1
40 Antimalarials Phase 1
41
Nicotine Approved 54-11-5 942 89594
42
Imiquimod Approved, Investigational Early Phase 1 99011-02-6 57469
43
Ethanol Approved 64-17-5 702
44
Heparin, bovine Approved, Investigational, Withdrawn Early Phase 1 9005-49-6 22833565 9812414 772
45 Anesthetics
46 Endothelial Growth Factors
47 Tea
48 Adjuvants, Immunologic Early Phase 1
49 interferons Early Phase 1
50 Anti-Inflammatory Agents Early Phase 1

Interventional clinical trials:

(show top 50) (show all 59)
# Name Status NCT ID Phase Drugs
1 The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor Recruiting NCT03017053 Phase 4
2 Comparing the Test Characteristics of Three Oral Cancer Screening Techniques:1)Unaided Visual Examination 2)VelScope Examination and 3)Toluidine Blue Application, by Trained Primary Health Care Workers in Mumbai, India. Unknown status NCT00655421 Phase 3
3 Canadian Optically Guided Approach for Oral Lesions Surgical Trial - COOLS Unknown status NCT01039298 Phase 3
4 Workplace Tobacco Cessation And Oral Cancer Screening Study Completed NCT00750503 Phase 3
5 Erlotinib Prevention of Oral Cancer (EPOC) Completed NCT00402779 Phase 3 Erlotinib;Placebo
6 Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer Recruiting NCT04333537 Phase 2, Phase 3 Imaging Agent
7 Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin Active, not recruiting NCT03258554 Phase 2, Phase 3
8 Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Completed NCT03638622 Phase 1, Phase 2
9 Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135] Completed NCT00064103 Phase 1, Phase 2
10 Phase II Trial of Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer Completed NCT03258008 Phase 2 Utomilumab
11 Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing Recruiting NCT02734537 Phase 2 Cisplatin
12 Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Patients With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study Recruiting NCT05136196 Phase 2 Cabozantinib S-malate
13 Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer Recruiting NCT03224000 Phase 2
14 A Phase II Trial of the Efficacy and Safety of the Combination of Cemiplimab and Low-Dose Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Recruiting NCT04862650 Phase 2 Carboplatin;Paclitaxel
15 A Phase I-II, FIH Study of A166 in Locally Advanced/Metastatic Solid Tumors Expressing Human Epidermal Growth Factor Receptor 2 (HER2) or Are HER2 Amplified That Did Not Respond or Stopped Responding to Approved Therapies Active, not recruiting NCT03602079 Phase 1, Phase 2 A166
16 Multimodality Therapy With Induction Carboplatin/Nab-Paclitaxel/Durvalumab Followed by Surgical Resection and Risk-adapted Adjuvant Therapy for the Treatment of Locally-Advanced and Surgically Resectable Squamous Cell Carcinoma of the Head and Neck Active, not recruiting NCT03174275 Phase 2 Durvalumab;Carboplatin;Nab-paclitaxel;Cisplatin
17 A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin Active, not recruiting NCT04541355 Phase 2 Cisplatin;Sodium Thiosulfate
18 Guided by Light: Optimizing Surgical Excision of Oral Cancer Using Real-time Fluorescence Imaging Not yet recruiting NCT04191460 Phase 2 cRGD-ZW800-1.
19 Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia With Tozuleristide, a Fluorescent Tumor Marking Agent Not yet recruiting NCT05316688 Phase 1, Phase 2 Tozuleristide
20 Phase I Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases Recruiting NCT03093909 Phase 1 Gemcitabine
21 Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma Recruiting NCT04576091 Phase 1 Elimusertib
22 Phase I/Ib Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer Recruiting NCT05172245 Phase 1 Cisplatin;Ipatasertib
23 A Phase Ib Investigation of Pembrolizumab in Combination With Intratumoral Injection of Clostridium Novyi-NT in Patients With Treatment-Refractory Solid Tumors Recruiting NCT03435952 Phase 1 Pembrolizumab;Doxycycline
24 Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients With Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Suspended NCT04533750 Phase 1 Peposertib
25 Phase I Study of Intraarterial ONYX-015 in Combination With Intravenous Cisplatin and Fluorouracil in Patients With Advanced Squamous Cell Cancer of the Head and Neck Withdrawn NCT00006106 Phase 1 cisplatin;fluorouracil;ONYX-015
26 A Phase I Study of Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies Withdrawn NCT02812056 Phase 1 Alisertib;TAK-228
27 A Phase I Trial of Lenvatinib (Multi-kinase Inhibitor) and Capecitabine (Anti-metabolite) in Patients With Advanced Malignancies Withdrawn NCT02915172 Phase 1 Lenvatinib;Capecitabine
28 Observational Study on the Carcinogenesis of Gα12 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using Ga12 Inhibitor. Unknown status NCT01919580
29 Observational Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using SOX-9 Inhibitor. Unknown status NCT01919567
30 Yeur-Hur Lai, PhD, RN, School of Nursing, College of Medicine, National Taiwan University Unknown status NCT04214912
31 The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions Unknown status NCT00173316
32 Dual-time PET/CT and Sentinel Node Diagnostics Preoperatively in Patients With Oral Cancer Unknown status NCT01136265
33 Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers Unknown status NCT03114501
34 Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective Study Unknown status NCT02866500
35 Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study Unknown status NCT02902406
36 Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer Completed NCT01084733
37 A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations Completed NCT00186433
38 Validation of DNA Methylation Biomarkers for Oral Cancer Detection Completed NCT01945697
39 Validation of DNA Methylation Biomarkers for Oral Cancer Detection Completed NCT02648789
40 Effectiveness of Green Tea Mouthwash on the Oral Health Status in Oral Cancer Patients: A Single-blind Randomized Clinical Trial and a CONSORT-compliant Article Completed NCT04615780
41 Retrospective Analysis Of Sensory Recovery Of Donor Size And Related Quality Life In Oral Cancer Patients Receiving Free Flap Reconstruction Completed NCT02048631
42 Rehabilitation Outcomes of Shoulder Function in Oral Cancer Survivors Cancer Survivors Completed NCT03545100
43 Epstein-Barr Detection in Squamous Cell Carcinoma and Healthy Oral Mucosa Completed NCT01039272
44 Clinical Evaluation of the OncAlert RAPID; Impact on Decision-Making Completed NCT03239834
45 Using an APP in Post Oral Cancer Surgery to Affect Patients' Needs and Quality of Life. Completed NCT04049968
46 Randomized Intervention Trial to Evaluate Oral Visual Inspection in the Control of Oral Cancer Completed NCT04494620
47 Web-based Education on Oral Cancer for Primary Care Physicians in Ohio Completed NCT01424358
48 Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention Completed NCT01351532
49 Integrated Cancer Repository for Cancer Research Recruiting NCT02012699
50 Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Recruiting NCT00568490

Search NIH Clinical Center for Lip Cancer

Cochrane evidence based reviews: lip neoplasms

Genetic Tests for Lip Cancer

Anatomical Context for Lip Cancer

Organs/tissues related to Lip Cancer:

MalaCards : Lymph Node, Endothelial, Lung, Skin, Tongue, Kidney, Salivary Gland

Publications for Lip Cancer

Articles related to Lip Cancer:

(show top 50) (show all 489)
# Title Authors PMID Year
1
Risk of Non-cutaneous Cancers in Individuals with Basal Cell Carcinoma: A Population-based Cohort Study. 62
36448850 2022
2
Inferiorly based nasolabial flap for reconstruction of full-thickness medium-sized lower lip and commissural defects following ablative cancer surgery. 62
36343273 2022
3
Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights. 62
36303015 2022
4
Contribution of Open Mouth Technique in 18F-FDG PET/CT Imaging in Patients with Malignant Lip Neoplasm. 62
36268853 2022
5
Deciphering miRNAs associated with cellular stress response and apoptosis mechanisms regulated by p53 activity in patients with lower lip cancer. 62
35724459 2022
6
High-dose-rate brachytherapy (interventional radiotherapy) in lip carcinoma with rigid needles: a simple technique with excellent results. 62
36199990 2022
7
Relevance of perimarginal nodes for head and neck cancer. 62
34448944 2022
8
Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis. 62
35626169 2022
9
Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients. 62
35494181 2022
10
Trends in mortality rates for oral and oropharyngeal cancer in Spain, 1979-2018. 62
33305413 2022
11
Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population? 62
35338330 2022
12
Temporal trends of women with oral cavity, base of tongue and lip cancers in Brazil: An ecological study covering mortality data from 1980 to 2018. 62
35156217 2022
13
Actinic cheilitis in rural workers: prevalence and associated factors. 62
35649060 2022
14
Immunohistochemical analysis of epithelium adjacent to lip cancer: A meta-analysis. 62
32945581 2022
15
A short review on DNA damage and repair effects in lip cancer. 62
33626329 2021
16
Immune checkpoint analysis in lip cancer. 62
34140198 2021
17
Cancer incidence among musicians: 45 years of follow-up in four Nordic countries. 62
34162315 2021
18
[Global oral health in the international health policy spotlight-challenges and new opportunities for sustainable improvement]. 62
34100957 2021
19
The relevance of miRNAs as promising biomarkers in lip cancer. 62
33439343 2021
20
Decreased Global Interest in Oral Cancer During the COVID-19 Pandemic. 62
34319034 2021
21
High dose interstitial brachytherapy for treatment of carcinoma of the lip as an alternative to surgery: a case report. 62
34824620 2021
22
Application of vermillion myocutaneous flap in restoration after lip cancer resection. 62
32951304 2020
23
State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients. 62
32629408 2020
24
Effects of Bauxite and Alumina Exposure on Incidence of Cancer - Meta-analysis. 62
34165102 2020
25
Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study. 62
32608576 2020
26
Cancer incidence among seafarers and fishermen in the Nordic countries. 62
31917456 2020
27
Predictive factors of late neck metastasis in early stage lip cancer followed by "wait and see" policy. 62
32526529 2020
28
Lower Lip Cancer Managed by Reconstruction with a Double Abbe Flap - A Case Report. 62
33708599 2020
29
Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies. 62
32068906 2020
30
The Upper Lip Squamous Cell Carcinoma the Role of Wedge Excision. 62
32068722 2020
31
Fusuma Sliding Flap for Lip Reconstruction of Lower Lip Cancer. 62
32209936 2020
32
High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer. 62
32266411 2020
33
Predictors of occult lymph node metastases in lip cancer. 62
32081379 2020
34
Erratum: Facial cutaneous metastases of advanced rectal malignancy masquerading as lip cancer. 62
32270784 2020
35
Analysis of the Filipinos' Interest in Searching Online for Oral Cancer. 62
32334480 2020
36
Pointless spatial modeling. 62
30202860 2020
37
Global patterns and trends in cancers of the lip, tongue and mouth. 62
31986342 2020
38
A Novel Method for Reconstruction of the Lower Lip After Lip Cancer Ablation: Double Abbe Flap. 62
31785249 2020
39
Detection of Occult Metastases in Patients with T1 and T2 Stage Lower Lip Squamous Cell Carcinomas after Positive Lymphoscintigraphy. 62
32053939 2020
40
Case report of a huge lower lip cancer successfully treated with intra-arterial infusion chemotherapy. 62
32446228 2020
41
Can immunohistochemical biomarkers distinguish epithelial dysplasia degrees in actinic cheilitis? A systematic review and meta-analysis. 62
31880283 2020
42
Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. 62
31673105 2019
43
A bibliometric analysis of the most cited articles about squamous cell carcinoma of the mouth, lips, and oropharynx. 62
31076327 2019
44
Predictive factors for late cervical metastasis in stage I and II squamous cell carcinoma of the lip. 62
31161362 2019
45
Cancer incidence and mortality after heart transplantation - A population-based national cohort study. 62
30821595 2019
46
The stem cell markers expression CD44v6 and podoplanin in lip cancer: clinical significance. 62
30770986 2019
47
Preoperative neutrophil lymphocyte ratio but not platelet lymphocyte ratio predicts survival and early relapse in patients with oral, pharyngeal, and lip cancer. 62
30633409 2019
48
Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases. 62
30652378 2019
49
Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection. 62
31139219 2019
50
Cancer incidence in the Agricultural Health Study after 20 years of follow-up. 62
30805813 2019

Variations for Lip Cancer

Expression for Lip Cancer

Search GEO for disease gene expression data for Lip Cancer.

Pathways for Lip Cancer

Pathways related to Lip Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.84 TP53 CDKN2A
2
Show member pathways
10.7 TP53 MIRLET7E
3 10.5 TP53 CDKN2A
4
Show member pathways
10.26 TP53 CDKN2A
5 9.85 TP53 CDKN2A

GO Terms for Lip Cancer

Biological processes related to Lip Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 replicative senescence GO:0090399 9.26 TP53 CDKN2A
2 miRNA-mediated gene silencing by inhibition of translation GO:0035278 8.8 MIRLET7E MIR345 MIR205

Sources for Lip Cancer

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....